KAREN TEDESCO M.D. NPI 1083601124

NPI Information

  • NPI: 1083601124
  • Provider Name: KAREN TEDESCO, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1700 RIVERFRONT CTR
    AMSTERDAM, NY
    ZIP 12010
  • Phone: (518) 843-0020

Map and Directions

Get Directions

NPI Details

Karen Tedesco, M.D. is a hematology and oncology internal medicine in Amsterdam, NY with 28 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Karen Tedesco, M.D. NPI is 1083601124. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: STATE UNIVERSITY OF NY UPSTATE MEDICAL UNIVERSITY
Graduation Year:1998

The provider's business location address is:

1700 RIVERFRONT CTR
AMSTERDAM, NY
ZIP 12010-620
Phone: (518) 843-0020
Fax: (518) 843-0023

The NPI 1083601124 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Measurement of substance using immunoassay technique (HCPCS:83520)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Folic acid level, serum (HCPCS:82746)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)

The enumeration date for this NPI number is 10/4/2005 and was last updated on 3/20/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology231176NEW YORKYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.